3 completed, 3 unknown, 1 withdrawn. 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Unknown 2 |
Follow Intec Pharma Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients Accordion Pill Carbidopa/Levodopa, Sinemet CR 25Mg-100Mg Extended-Release Tablet - Parkinson Disease | Phase 2 | Unknown | Intec Pharma Ltd. | 12 | 2018-07-01 | 2018-07-05 |
| A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 Accordion Pill™ Carbidopa/Levodopa - Parkinson's Disease | Phase 3 | Unknown | Intec Pharma Ltd. | 460 | 2016-07-01 | 2018-08-14 |
| A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD - Parkinson's Disease | Phase 3 | Unknown | Intec Pharma Ltd. | 420 | 2016-03-01 | 2019-08-08 |
| Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study AP-CD/LD - Parkinson's Disease | Phase 2 | Withdrawn | Intec Pharma Ltd. | 2012-08-01 | 2015-11-24 | |
| A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia Zaleplon AP formulation, Placebo capsule - Insomnia | Phase 2 | Completed | Intec Pharma Ltd. | 83 | 2011-01-01 | 2014-12-19 |
| Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep IN 10 003 formulation A, IN 10 003 formulation B, Placebo capsules - Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep | Phase 2 | Completed | Intec Pharma Ltd. | 24 | 2010-09-01 | 2011-05-03 |
| An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease AP09004, Carbidopa/Levodopa, immediate release - Parkinson's Disease | Phase 2 | Completed | Intec Pharma Ltd. | 72 | 2009-07-01 | 2014-05-28 |
Parkinson Disease (5) · Sleep Initiation and Maintenance Disorders (1)
Levodopa (3) · carbidopa, levodopa drug combination (3) · Carbidopa (1)
Israel (6) · United States (3) · Bulgaria (2) · Germany (2) · Italy (2) · Poland (2) · Slovakia (2) · Spain (2) · Ukraine (2) · United Kingdom (2)
Ilana Schlesinger Schlesinger, MD (1) · Marieta Anca-Herschkovitsch, M.D (1) · O. Cohen, MD (1) · Peter A LeWitt, MD (1) · Peter Farkas, M.D (1) · Peter LeWitt, MD (1) · R. Djaldetti, Prof. MD (1) · Ron Milo, M.D (1) · T Gurevich, MD (1)
2018 (1)